< Back to scientific publications

Report/Poster of Convention/Congress Act

Poor Mobilizer” with myeloma or lymphoma. Experience of the”Tor Vergata”Polyclinic Stem Cell Collection Center

Authors: Fiorelli E., Lanti A., Ferraro A.S., D’Alessandro E., Chiru O.M., Del Proposto G., Cerrone P., De Angelis L., Guiducci G., Zinno F., Adorno G., Isacchi G., “ Plerixafor in association with G-CSF as a mobilization regimen in patients

Date: 2014

Scope of interest: Clinical pathology




You may also be interested in:

Magazine

The efficacy of Choep chemotherapy regimen administered in association with monoclonalantibody anti-CD52 Alemtuzumab in cutaneous T-celllymphoma (CTCL) and systemic T-celllymphoma with cutaneous involvement (PTCL)

Authors: Postorino M, De Santis G, Marchesi F, Provenzano I, Franceschini L, Pupo L, Rizzo M, Giannì L, Gumenyuk S, Tonialini L, Fiorelli E, Renzi D, Zizzari A.

Date: 2013

Scope of interest: Haematology


Read details
Magazine 2.12

“Pulmonary Covid Fibrosis a new pharmaceutical approach”

Authors: Menicagli r

Date: 2020

Scope of interest: infectivology


Read details
Report/Poster of Convention/Congress Act

Use of hyperimmune plasma for compassionate use in patients with Marginal Non-Hodgkin Lymphoma persistently positive for SARS-CoV-2 infection

Authors: Cristina D'Amico (1) - Federico De Angelis (1) - Elena Gigliotti (1) - Maria Trimboli (1) - Giorgia Guiducci (1) - Francesca Docimo (1) - Paolo Paesano (1) - Antonietta Arduini (1) - Francesca Chiarlitti (1) - Manuela Alo' (1) - Carla Gargiulo (1)

Date: 2022

Scope of interest: Clinical pathology


Read details